Positive 28 Sep, 22:39 Impact +7

Moderna Shares Rise 26% as Investors Focus on Growth Beyond COVID Vaccines

Product 16 Sep, 21:30 Impact +5

Moderna second approved product in Canada, the first mRNA vaccine against RSV, and the only one in single-dose pre-filled syringes Canada is the fourth jurisdiction to approve mRESVIA following approvals in the U.S., Europe, and Qatar

Positive 16 Sep, 21:30 Impact +5

Trump Administration Lifts Block on Moderna's Flu Vaccine Trials

Negative 27 Aug, 14:24 Impact +5

Moderna to Issue $2 Billion in Convertible Bonds Amid Negative Market Sentiment

Positive 20 Aug, 11:30 Impact +7

Moderna Cancer Vaccine Progress Sparks Biopharma Rally

Positive 20 Aug, 11:15 Impact +8

Moderna Posts Largest One-Day S&P 500 Gain of the 21st Century

Positive 20 Aug, 11:03 Impact +8

Moderna Shares More Than Double After Success of mRNA Cancer Vaccine

Positive 20 Aug, 10:10 Impact +8

Moderna shares nearly triple on skin cancer vaccine success

Positive 20 Aug, 09:13 Impact +9

Moderna Shares Rise 177% After Skin Cancer Vaccine Trial Success

Positive 19 Aug, 19:01 Impact +9

Moderna shares surge 128% after positive mRNA cancer vaccine trial news

Positive 19 Aug, 17:56 Impact +7

Merck and Moderna report encouraging melanoma vaccine trial results

Positive 19 Aug, 17:23 Impact +3

Moderna Shares Rise 150%

Positive 19 Aug, 16:33 Impact +7

Moderna Shares Rise 90% at the Open on Cancer Vaccine Hopes

Positive 19 Aug, 14:52 Impact +8

Moderna and Merck Shares Rise

Positive 19 Aug, 14:13 Impact +5

Moderna (MRNA) Rises 55%

Neutral 31 Jul, 14:02 Impact +5

Moderna Reports Financial Results, Sentiment Remains Neutral